Cambridge researchers have discovered new potential avenues for the treatment of certain forms of cancer, which carry mutations affecting the KRAS gene.
Where did it all go wrong? Scientists identify ‘cell of origin’, or the first cell from which the cancer grows, in the most common form of skin cancer.